Advertisement

Overview of the Intensive Care of the Adult with Congenital Heart Disease

  • Jeremy Nicolarsen
  • Joseph Kay
Chapter
Part of the Congenital Heart Disease in Adolescents and Adults book series (CHDAA)

Abstract

There are now more adults than children living with congenital heart disease, many of whom have moderately to severely complex defects. As a group, these patients are hospitalized more than the general population, and many require intensive care. Adults with congenital heart disease are a highly variable group of patients, many of whom have antecedent chronic medical problems that may complicate or be complicated by critical illness, such as congestive hepatopathy and hepatic disease, renal impairment, arrhythmia, coagulopathy, and thrombosis. The intensive care team, whether in a children’s or adult hospital, needs to be prepared to handle this growing population of patients.

Keywords

Adult congenital heart disease ACHD Intensive care unit ICU Hepatic disease Renal impairment Arrhythmia Coagulopathy Thrombosis 

References

  1. 1.
    Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37(5):1170–5.CrossRefGoogle Scholar
  2. 2.
    Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2):163–72.CrossRefGoogle Scholar
  3. 3.
    Mackie AS, Pilote L, Ionescu-Ittu R, Rahme E, Marelli AJ. Health care resource utilization in adults with congenital heart disease. Am J Cardiol. 2007;99(6):839–43.CrossRefGoogle Scholar
  4. 4.
    Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda GT, et al. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010;96(11):872–8.CrossRefGoogle Scholar
  5. 5.
    Kaemmerer H, Bauer U, Pensl U, Oechslin E, Gravenhorst V, Franke A, et al. Management of emergencies in adults with congenital cardiac disease. Am J Cardiol. 2008;101(4):521–5.CrossRefGoogle Scholar
  6. 6.
    Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54(5):460–7.CrossRefGoogle Scholar
  7. 7.
    Blalock A. The technique of creation of an artificial ductus arteriosus in the treatment of pulmonic stenosis. J Thorac Surg. 1947;16(3):244–57.PubMedGoogle Scholar
  8. 8.
    Pierce WS, Waldhausen JA, Berman W Jr, Whitman V. Late results of the subclavian flap procedure in infants with coarctation of the thoracic aorta. Circulation. 1978;58(3 Pt 2):I78–82.PubMedGoogle Scholar
  9. 9.
    Wang A, Book WM, McConnell M, Lyle T, Rodby K, Mahle WT. Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992. Am J Cardiol. 2007;100(8):1307–9.CrossRefGoogle Scholar
  10. 10.
    Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, et al. Congenital heart disease and the liver. Hepatology. 2012;56:1160.CrossRefGoogle Scholar
  11. 11.
    Shteyer E, Yatsiv I, Sharkia M, Milgarter E, Granot E. Serum transaminases as a prognostic factor in children post cardiac surgery. Pediatr Int. 2011;53(5):725–8.CrossRefGoogle Scholar
  12. 12.
    Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117(18):2320–8.CrossRefGoogle Scholar
  13. 13.
    Somerville J. Management of adults with congenital heart disease: an increasing problem. Annu Rev Med. 1997;48:283–93.CrossRefGoogle Scholar
  14. 14.
    Khairy P, Aboulhosn J, Gurvitz MZ, Opotowsky AR, Mongeon FP, Kay J, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122(9):868–75.CrossRefGoogle Scholar
  15. 15.
    Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006;27(17):2099–140.CrossRefGoogle Scholar
  16. 16.
    Lam W, Friedman RA. Electrophysiology issues in adult congenital heart disease. Methodist Debakey Cardiovasc J. 2011;7(2):13–7.CrossRefGoogle Scholar
  17. 17.
    Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011;13:9.CrossRefGoogle Scholar
  18. 18.
    Backer CL. 12th annual C. Walton Lillehei memorial lecture in cardiovascular surgery: Fontan conversion—the Chicago experience. Cardiol Young. 2011;21(Suppl 2):169–76.CrossRefGoogle Scholar
  19. 19.
    Diller GP, Giardini A, Dimopoulos K, Gargiulo G, Muller J, Derrick G, et al. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J. 2010;31(24):3073–83.CrossRefGoogle Scholar
  20. 20.
    Odegard KC, McGowan FX Jr, Zurakowski D, DiNardo JA, Castro RA, del Nido PJ, et al. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg. 2002;73(6):1770–7.CrossRefGoogle Scholar
  21. 21.
    Odegard KC, McGowan FX Jr, Zurakowski D, Dinardo JA, Castro RA, del Nido PJ, et al. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg. 2003;125(6):1260–7.CrossRefGoogle Scholar
  22. 22.
    Jensen AS, Johansson PI, Bochsen L, Idorn L, Sorensen KE, Thilen U, et al. Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease. Int J Cardiol. 2013;167(5):2210–4.CrossRefGoogle Scholar
  23. 23.
    Sandoval J, Santos LE, Cordova J, Pulido T, Gutierrez G, Bautista E, et al. Does anticoagulation in Eisenmenger syndrome impact long-term survival? Congenit Heart Dis. 2012;7(3):268–76.CrossRefGoogle Scholar
  24. 24.
    Valente AM, Bhatt AB, Cook S, Earing MG, Gersony DR, Aboulhosn J, et al. The CALF (congenital heart disease in adults lower extremity systemic venous health in Fontan patients) study. J Am Coll Cardiol. 2010;56(2):144–50.CrossRefGoogle Scholar
  25. 25.
    Dimopoulos K, Diller GP, Giannakoulas G, Petraco R, Chamaidi A, Karaoli E, et al. Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol. 2009;54(22):2093–100.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Providence Adult and Teen Congenital Heart Program (PATCH)Providence Sacred Heart Medical Center and Children’s HospitalSpokaneUSA
  2. 2.Colorado’s Adult and Teen Congenital Heart Program (CATCH), Department of CardiologyUniversity of Colorado Hospital and Children’s Hospital ColoradoAuroraUSA

Personalised recommendations